MAS1L and mild neurocognitive disorder: Activation of the ACE2/Ang (1–7) neuronal axis/Mas R promotes neuroprotection via antioxidant and anti-inflammatory effects and could have great potential om the development of new therapeutic options for pathologies including PD, AD, MS, HD, MND, or PRD.